BlackRock Investment Management’s Pacific Biosciences PACB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.55M	Sell	409,177 -2,095	-0.5%	-$15.2K	﹤0.01%	2392
2016 Q3	$3.69M	Buy	411,272 +15,232	+4%	+$127K	﹤0.01%	1704
2016 Q2	$2.79M	Buy	396,040 +45,768	+13%	+$418K	﹤0.01%	1861
2016 Q1	$2.98M	Buy	350,272 +27,353	+8%	+$269K	﹤0.01%	1731
2015 Q4	$4.24M	Sell	322,919 -12,513	-4%	-$112K	0.01%	1503
2015 Q3	$1.23M	Sell	335,432 -65,099	-16%	-$318K	﹤0.01%	2451
2015 Q2	$2.31M	Buy	400,531 +27,202	+7%	+$157K	﹤0.01%	2111
2015 Q1	$2.18M	Buy	373,329 +13,803	+4%	+$95.2K	﹤0.01%	1955
2014 Q4	$2.82M	Buy	359,526 +191,521	+114%	+$1.23M	﹤0.01%	1774
2014 Q3	$825K	Buy	168,005 +2,603	+2%	+$13.6K	﹤0.01%	2652
2014 Q2	$1.02M	Sell	165,402 -8,841	-5%	-$44.2K	﹤0.01%	2590
2014 Q1	$932K	Buy	174,243 +11,486	+7%	+$72.6K	﹤0.01%	2554
2013 Q4	$851K	Sell	162,757 -2,403	-1%	-$11K	﹤0.01%	2610
2013 Q3	$912K	Buy	165,160 +9,442	+6%	+$32.8K	﹤0.01%	2509
2013 Q2	$394K	Buy	+155,718	New	+$388K	﹤0.01%	2970